Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).

Jereczek-Fossa BA, Rojas DP, Zerini D, Fodor C, Viola A, Fanetti G, Volpe S, Luraschi R, Bazani A, Rondi E, Cattani F, Vavassori A, Garibaldi C, Alessi S, Pricolo P, Petralia G, Cozzi G, De Cobelli O, Musi G, Orecchia R, Marvaso G, Ciardo D.

Br J Radiol. 2018 Nov 9:20180494. doi: 10.1259/bjr.20180494. [Epub ahead of print]

PMID:
30379566
2.

Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.

Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, Amiel J, Kee DL, Hannoun-Lévi JM.

Radiat Oncol. 2017 Mar 9;12(1):49. doi: 10.1186/s13014-017-0789-9.

3.

Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.

Zerini D, Jereczek-Fossa BA, Fodor C, Bazzani F, Maucieri A, Ronchi S, Ferrario S, Colangione SP, Gerardi MA, Caputo M, Cecconi A, Gherardi F, Vavassori A, Comi S, Cambria R, Garibaldi C, Cattani F, De Cobelli O, Orecchia R.

Br J Radiol. 2015 Aug;88(1052):20150197. doi: 10.1259/bjr.20150197. Epub 2015 Jun 9.

4.

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center.

Leroy T, Lacornerie T, Bogart E, Nickers P, Lartigau E, Pasquier D.

Radiat Oncol. 2017 Jun 9;12(1):95. doi: 10.1186/s13014-017-0833-9.

5.

Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.

Repka MC, Aghdam N, Kataria SK, Campbell L, Suy S, Collins SP, Anderson E, Lischalk JW, Collins BT.

Radiat Oncol. 2017 Oct 19;12(1):162. doi: 10.1186/s13014-017-0897-6.

6.

High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.

Fuller DB, Wurzer J, Shirazi R, Bridge SS, Law J, Mardirossian G.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e615-23. doi: 10.1016/j.prro.2015.04.009. Epub 2015 Jun 6.

PMID:
26059509
7.

Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.

Hashmi A, Guckenberger M, Kersh R, Gerszten PC, Mantel F, Grills IS, Flickinger JC, Shin JH, Fahim DK, Winey B, Oh K, John Cho BC, Létourneau D, Sheehan J, Sahgal A.

J Neurosurg Spine. 2016 Nov;25(5):646-653. Epub 2016 Jun 24.

PMID:
27341054
8.

Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung.

Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI.

Front Oncol. 2015 Jan 14;4:376. doi: 10.3389/fonc.2014.00376. eCollection 2014.

10.

Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience.

Ponti E, Ingrosso G, Carosi A, Di Murro L, Lancia A, Pietrasanta F, Santoni R.

Clin Genitourin Cancer. 2015 Aug;13(4):e279-e284. doi: 10.1016/j.clgc.2014.12.014. Epub 2014 Dec 30.

PMID:
25604915
11.

Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.

Janoray G, Reynaud-Bougnoux A, Ruffier-Loubière A, Bernadou G, Pointreau Y, Calais G.

Cancer Radiother. 2016 Jun;20(4):275-81. doi: 10.1016/j.canrad.2016.03.005. Epub 2016 Jun 21.

PMID:
27342944
12.

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.

Wild AT, Hiniker SM, Chang DT, Tran PT, Khashab MA, Limaye MR, Laheru DA, Le DT, Kumar R, Pai JS, Hargens B, Sharabi AB, Shin EJ, Zheng L, Pawlik TM, Wolfgang CL, Koong AC, Herman JM.

J Gastrointest Oncol. 2013 Dec;4(4):343-51. doi: 10.3978/j.issn.2078-6891.2013.044.

13.

Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes.

Barbera F, Triggiani L, Buglione M, Ghirardelli P, Vitali P, Caraffini B, Borghetti P, Greco D, Bardoscia L, Pasinetti N, Costa L, Maddalo M, Ghedi B, La Face B, Magrini SM.

Clin Med Insights Oncol. 2017 Nov 7;11:1179554917738765. doi: 10.1177/1179554917738765. eCollection 2017.

14.

Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.

Zilli T, Benz E, Dipasquale G, Rouzaud M, Miralbell R.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):318-322. doi: 10.1016/j.ijrobp.2016.05.024. Epub 2016 May 28.

PMID:
27475672
15.

Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.

Buchser D, Gomez-Iturriaga A, Melcon JI, Casquero F, Llarena R, Cacicedo J, Bilbao P.

J Contemp Brachytherapy. 2016 Dec;8(6):477-483. doi: 10.5114/jcb.2016.64441. Epub 2016 Dec 6.

16.

Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.

Jereczek-Fossa BA, Fanetti G, Fodor C, Ciardo D, Santoro L, Francia CM, Muto M, Surgo A, Zerini D, Marvaso G, Timon G, Romanelli P, Rondi E, Comi S, Cattani F, Golino F, Mazza S, Matei DV, Ferro M, Musi G, Nolè F, de Cobelli O, Ost P, Orecchia R.

Clin Genitourin Cancer. 2017 Aug;15(4):e623-e632. doi: 10.1016/j.clgc.2017.01.004. Epub 2017 Jan 11.

PMID:
28185875
17.

Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.

Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M 3rd, Gottschalk AR.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):228-34. doi: 10.1016/j.ijrobp.2010.10.026. Epub 2010 Dec 22.

PMID:
21183287
18.
19.

Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation.

Baumann BC, Baumann JC, Christodouleas JP, Soffen E.

Brachytherapy. 2017 Mar - Apr;16(2):291-298. doi: 10.1016/j.brachy.2016.12.011. Epub 2017 Jan 27.

PMID:
28139422
20.

Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation.

Sutera P, Bernard ME, Wang H, Bahary N, Burton S, Zeh H, Heron DE.

Front Oncol. 2018 Mar 7;8:52. doi: 10.3389/fonc.2018.00052. eCollection 2018.

Supplemental Content

Support Center